MarketsandMarkets

Protein Engineering Market Worth $168 Billion by 2017

The global market was estimated at $100.1 billion in 2012, growing at a CAGR of 10.94% from 2012 to 2017.

 

Dallas, TX -- (ReleaseWire) -- 03/20/2014 -- The report "Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017", analyses the global protein engineering market by products, technology, applications, and geography with five-year revenue forecasts. It also identifies the factors driving and restraining the global protein engineering market with analysis of trends, opportunities, and threats.

Browse 11 market data tables with 44 figures spread through 148 Slides and in-depth TOC on "Protein Engineering Market".
Early buyers will receive 10% customization on this report.

Do Inquiry Before Buying@
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=898

The global market for engineered protein products is estimated to be worth $168 billion by 2017, growing at a CAGR of 10.94% from 2012 to 2017. Proteins are used as therapeutics owing to their specificity and less immunogenic responses within the host system. Diversity in protein architecture and its properties offers scope for new and improved versions of therapeutic proteins with improved function and stability. The market for engineered protein products is growing due to an increase in prevalence of cancer, autoimmune, inflammatory, and infectious diseases.

Ask for a free copy of PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=898

North America is the major market, accounting for 42% of the market; it is expected to grow at a CAGR of 10%. Asia, however, is the fastest growing region with estimated CAGR of 13.5%. These diseases need a targeted therapeutic approach for treatment, which is achieved by therapeutic proteins. Monoclonal antibody is the fastest growing product segment in the market with more than 50% market share. There are more than 25 monoclonal antibodies approved for therapeutics; 10 of these are blockbuster drugs with more than $1 billion in annual revenue. Other products like insulin analogs, EPO, enzymes, and growth hormones are expected to grow at a medium pace.

Key players in the market include Genentech (U.S.), Amgen (U.S.), Roche (Switzerland), Eli Lilly (U.S.), Novartis (Switzerland),GlaxoSmithKline (U.K.),Bristol-Myers Squibb (U.S.), Johnson & Johnson (U.S.), Merck (U.S.), Pfizer (U.S.), Sanofi (France), Affymax (U.S.), Biogen Idec, (U.S.), Medimmune (U.S.) Affimed (Germany), and Obodies (New Zealand).

Browse Related Reports:
Global Transfection Technologies Market (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) And Types (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) (2012 – 2017)
http://www.marketsandmarkets.com/Market-Reports/transfection-technologies-market-895.html

Protein Crystallization & Crystallography Market by Technology (Ion-Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents & Instruments) & End-Users (Pharmaceutical & Biotechnology Companies) - Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/protein-crystallization-market-147057058.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets